Falcon Point Capital’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-12,293
Closed -$806K 83
2020
Q1
$806K Sell
12,293
-2,123
-15% -$169K 1.75% 14
2019
Q4
$1.18M Sell
14,416
-37,635
-72% -$2.89M 1.5% 17
2019
Q3
$3.66M Buy
52,051
+7,286
+16% +$535K 2.01% 20
2019
Q2
$3.85M Buy
44,765
+8,681
+24% +$706K 2.07% 18
2019
Q1
$2.92M Sell
36,084
-42,293
-54% -$3.17M 1.59% 26
2018
Q4
$4.8M Sell
78,377
-105,322
-57% -$7.13M 2.87% 6
2018
Q3
$13.2M Sell
183,699
-41,126
-18% -$2.59M 2.84% 6
2018
Q2
$11.8M Buy
224,825
+105,215
+88% +$4.95M 2.32% 11
2018
Q1
$5.19M Buy
+119,610
New +$5.5M 1.04% 42

Other funds holding OMCL

Falcon Point Capital's OMCL Position: Q2 2020 in Review

Falcon Point Capital sold out of Omnicell (OMCL) in Q2 2020, closing a stake of 12,293 shares — an estimated $806K sold.

Falcon Point Capital first reported a position in OMCL in Q1 2018 and held it in 9 quarters. The position peaked at $13.2M in Q3 2018. 295 funds tracked by Wall St. Rank hold OMCL as of Q2 2020.

  • Falcon Point Capital reported no remaining Omnicell position as of Q2 2020 after selling out during the quarter.
  • Falcon Point Capital sold 12,293 Omnicell shares in Q2 2020, an estimated $806K.
  • Falcon Point Capital first reported a position in Omnicell in Q1 2018 and held it in 9 quarters.
  • Falcon Point Capital's Omnicell position peaked at $13.2M in Q3 2018.
  • 295 funds tracked by Wall St. Rank held Omnicell as of Q2 2020.

Based on Falcon Point Capital's 13F filing for Q2 2020, filed 21 Jul 2020.